Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/02/2010 | US20100221309 Film compositions for delivery of actives |
09/02/2010 | US20100221308 Antimicrobial compositions and uses thereof |
09/02/2010 | US20100221307 Antiviral agents, antiviral fibers and antiviral fiber structures |
09/02/2010 | US20100221305 Formulations for coated microprojections containing non-volatile counterions |
09/02/2010 | US20100221303 Method for Preparing Porous Scaffold for Tissue Engineering, Cell Culture and Cell Delivery |
09/02/2010 | US20100221302 Delivery System For Heparin-Binding Growth Factors |
09/02/2010 | US20100221300 Processing of Angiogenic Scaffolds for Large Organ Regeneration |
09/02/2010 | US20100221299 Therapeutic stem cell nutrient composition and uses thereof |
09/02/2010 | US20100221298 Novel galenical system for active transport, method for preparation and use |
09/02/2010 | US20100221296 Oil-in-water emulsion containing an amphiphilic polymer and a silicone elastomer |
09/02/2010 | US20100221293 Controlled release formulations of opioid and nonopioid analgesics |
09/02/2010 | US20100221292 Injection molding process for the preparation of an oral delivery device for the pharmaceutically active agent |
09/02/2010 | US20100221291 Collagen tubes |
09/02/2010 | US20100221195 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
09/02/2010 | US20100221194 Topical foam composition |
09/02/2010 | US20100221190 Method for producing a particle comprising a gas core and a shell and particles thus obtained |
09/02/2010 | US20100221147 Dialysate of peritoneal dialysis and its preparation method |
09/02/2010 | CA2753993A1 A controlled release micro-capsule for osteogenic action |
09/02/2010 | CA2753753A1 Devices, systems and methods for magnetic-assisted therapeutic agent delivery |
09/02/2010 | CA2753742A1 Phospholipid and protein tablets |
09/02/2010 | CA2753497A1 Topical foam composition |
09/02/2010 | CA2753426A1 Coenzyme q10-containing composition for oral ingestion |
09/02/2010 | CA2753330A1 Uses of nk receptor antagonists |
09/02/2010 | CA2753316A1 Magnesium oxide granules |
09/02/2010 | CA2751321A1 Methods of administering (4ar, 1oar)-1-n-propyl-1,2,3,4a,5,10,10a-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof |
09/02/2010 | CA2751299A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
09/01/2010 | EP2223913A1 Tricyclic pyrazole derivatives and microemulsions thereof as CB1- and/or CB2-inhibitors |
09/01/2010 | EP2223758A2 Method for producing polymer coating on particle surfaces |
09/01/2010 | EP2223703A1 External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
09/01/2010 | EP2223702A1 Core particle for pharmaceutical preparation |
09/01/2010 | EP2223689A1 Plastic container having cyclic polyolefin layer |
09/01/2010 | EP2223686A2 Patch and patch preparation |
09/01/2010 | EP2223685A1 Non-gelatin enteric hard capsule shell and preparation method thereof |
09/01/2010 | EP2223684A2 Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof |
09/01/2010 | EP2223683A1 Oral powder and granular antitumor agent |
09/01/2010 | EP2223682A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
09/01/2010 | EP2223681A1 Compositions of spores of non pathogenic bacteria |
09/01/2010 | EP2223082A1 Device for determining the bioadhesiveness of pasty preparations |
09/01/2010 | EP2222754A2 Thermoresponsive arginine-based hydrogels as biologic carriers |
09/01/2010 | EP2222714A2 Polysaccharide gel compositions and methods for sustained delivery of drugs |
09/01/2010 | EP2222710A1 Recombinant rsv antigens |
09/01/2010 | EP2222340A1 Nanoemulsions |
09/01/2010 | EP2222327A2 Topical application and formulation of erythropoietin for skin wound healing |
09/01/2010 | EP2222285A1 Pharmaceutical compositions |
09/01/2010 | EP2222284A1 Prolonged release of local anesthetics using microparticles and surgery applications |
09/01/2010 | EP2222283A2 Yeast cell wall protein (ycwp) encapsulated multilayered nanoparticles for nucleic acid delivery (sirna) |
09/01/2010 | EP2222282A1 Dosage forms comprising celecoxib providing both rapid and sustained pain relief |
09/01/2010 | EP2222281A1 Process for preparing microparticles having a low residual solvent volume |
09/01/2010 | EP2222280A2 Slow release compositions |
09/01/2010 | EP2222279A2 Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids |
09/01/2010 | EP2222278A1 Improved taxane delivery system |
09/01/2010 | EP2222277A1 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases |
09/01/2010 | EP2222276A1 Stable elsamitrucin salt formulations |
09/01/2010 | EP2222274A2 Methods and compositons for enhancing the viability of microneedle pores |
09/01/2010 | EP2222273A2 Liquid compositions comprising valsartan |
09/01/2010 | EP2222272A1 Respiratory disease treatment |
09/01/2010 | EP2222168A1 Solvent systems for pour-on formulations for combating parasites |
09/01/2010 | EP1962806B1 Pre-compacted calcium-containing compositions |
09/01/2010 | EP1928428B1 A pharmaceutical formulation containing olanzapine |
09/01/2010 | EP1613347B1 Humanized antibodies that recognize beta amyloid peptide |
09/01/2010 | EP1472211B1 Emollients and cosmetic compositions |
09/01/2010 | EP1451144B1 Compositions for treating acne comprising phytandiol amine |
09/01/2010 | CN201564811U Traditional medicinal tablet for treating nephritis |
09/01/2010 | CN1989956B Adapalene gel composition and its preparation |
09/01/2010 | CN1969855B Pharmaceutical composition having target organ protection function and usage thereof |
09/01/2010 | CN1876103B Modified 'Shuang Huanglian' medicinal liquor for birds and preparation method thereof |
09/01/2010 | CN1857345B Hemicrania treating medicine composition and its preparing method |
09/01/2010 | CN1846721B Tranquilizing seven-leaf oral cavity disintegrated tablet and its preparation method |
09/01/2010 | CN1836729B Target antibody compound for killing tumour cell and its preparation method |
09/01/2010 | CN1565475B Product for prevention and treatment for virus infection of respiratory tract |
09/01/2010 | CN1523997B Stabilized interleukin 2 |
09/01/2010 | CN101821283A Use of SLIT, NEPHRIN, ephrin or semaphorin for treatment of cartilage diseases |
09/01/2010 | CN101820919A Injectable polymer-lipid blend for localized drug delivery |
09/01/2010 | CN101820918A Novel taxoid-based compositions |
09/01/2010 | CN101820913A Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
09/01/2010 | CN101820893A Granular jelly beverage for medication and process for producing the same |
09/01/2010 | CN101820887A Controlled release interferon drug products and treatment of hcv infection using sam |
09/01/2010 | CN101820876A Method for treating acute pain with formulated drug depot in combination with liquid formulation |
09/01/2010 | CN101820874A Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue |
09/01/2010 | CN101820867A 固体缬沙坦组合物 Solid compositions of Valsartan |
09/01/2010 | CN101820866A Mechanical protective layer for solid dosage forms |
09/01/2010 | CN101820865A Improvements relating to anti-HIV tablet formulations |
09/01/2010 | CN101820864A Nucleic acid-lipopolymer compositions |
09/01/2010 | CN101820863A Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof |
09/01/2010 | CN101820862A Method for stabilizing phenylephrine |
09/01/2010 | CN101820861A Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
09/01/2010 | CN101820860A Topical composition |
09/01/2010 | CN101820859A Process for the manufacure of pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate |
09/01/2010 | CN101820838A Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms |
09/01/2010 | CN101818044A Organogel of dipeptide-like and preparation method thereof |
09/01/2010 | CN101817800A Novel medicaments for the treatment of chronic obstructive pulmonary diseases |
09/01/2010 | CN101816797A Gold nanoparticles used as medicament carrier and method for preparing same |
09/01/2010 | CN101816796A Chinese medicament five-feng amino acid nutritional plaster matrix and preparation of externally applied nutritional plaster of same |
09/01/2010 | CN101816790A Spray for treating radioactive xerostomia and preparation method thereof |
09/01/2010 | CN101816787A An allergen dosage form |
09/01/2010 | CN101816782A Composite enzyme apophlegmatisant |
09/01/2010 | CN101816781A Gene recombinant human Cu-Zn superoxide dismutase liposome enteric-coated capsule and preparation method thereof |
09/01/2010 | CN101816780A Injectable bone growth factor-carrying microspheres and preparation method thereof |
09/01/2010 | CN101816774A Medicinal powder for nourishing blood, regulating menstruation and removing maculae |
09/01/2010 | CN101816771A Chinese medicinal composition for treating epilepsy disease and preparation method thereof |